Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress'

Ovarian cancer drug RC88 by RemeGen received FDA approval for Phase 2 clinical trials. Gynecologic oncologist Dr. Brian Slomovitz and other experts weighed in on the drug's potential.


http://dlvr.it/T21ZkX